6 recruiting. 6 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 6 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Lichen Planus: new trials by email Literature Review of Lichen Planus trials Research Report on Lichen Planus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus Placebo, GIA632 - Cutaneous Lichen Planus | Phase 2 | Recruiting | Novartis Pharmaceuticals | 259 | 2026-09-29 | 2026-10-13 |
| Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris Delgocitinib - Central Centrifugal Cicatricial Alopecia, Lichen Planopilaris | Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 30 | 2026-05-19 | 2026-07-10 |
| A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris Oral Brepocitinib, Placebo - Lichen Planopilaris | Phase 2 / Phase 3 | Recruiting | Priovant Therapeutics, Inc. | 342 | 2026-03-19 | 2026-07-08 |
| Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus Topical Bromelain, 0.1% topical triamcinolone acetonide, Combination of Topical Bromelain and Triamcinolone Acetonide in Orabase - Oral Lichen Planus | Phase 2 | Recruiting | Cairo University | 42 | 2026-02-18 | 2026-06-09 |
| Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus Clobetasol Patch, Clobetasol + Resveratrol Patch, Clobetasol in Orabase - Oral Lichen Planus, Oral Lichen Planus Related Stress | Phase 2 | Recruiting | University of Palermo | 45 | 2024-09-04 | 2025-08-03 |
| Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus Tacrolimus modified-release, tacrolimus ointment 0.1% - Oral Erosive Lichen Planus | Phase 1 / Phase 2 | Recruiting | Hospital de Clinicas de Porto Alegre | 46 | 2024-09-03 | 2024-10-02 |
Lichenoid Eruptions (6) · Skin Diseases (6) · Skin Diseases, Papulosquamous (6) · Skin and Connective Tissue Diseases (6) · Mouth Diseases (3) · Stomatognathic Diseases (3)
Orabase (2) · Bromelains (1) · Clobetasol (1) · Resveratrol (1) · Triamcinolone Acetonide (1) · delgocitinib (1)
Cairo University (1) · Hospital de Clinicas de Porto Alegre (1) · Icahn School of Medicine at Mount Sinai (1) · Novartis Pharmaceuticals (1) · Priovant Therapeutics, Inc. (1) · University of Palermo (1)
United States (3) · Australia (2) · Canada (2) · Brazil (1) · China (1) · Egypt (1) · Italy (1) · United Kingdom (1)
Benjamin Ungar, MD (1) · Fernanda Visioli, DDS, PhD (1)
2025 (1)